Case Reports| Volume 34, ISSUE 4, P561-565, August 2021

Two Concurrent Cancers in a 19-Year-Old Patient: Yolk Sac Ovarian Tumor and Metastatic Gastrointestinal Tract Malignancy—Case Report

Published:March 05, 2021DOI:



      Two concurrent malignancies present in a young person is an extremely rare condition. Diagnoses of gastric cancer primarily concern older patients. There are very few reports of concomitant Krukenberg tumor and germ-cell ovarian malignancy.


      A 19-year-old girl was admitted to the gynecologic oncology department with symptoms of advanced malignancy. Radiological imaging revealed disseminated neoplastic disease with bulky adnexal tumors. Cytoreductive surgery was performed, achieving no visible disease (T = 0 cm). The final pathology report confirmed metastatic mixed adenoneuroendocrine carcinoma (MANEC) in both ovaries, originating from the gastrointestinal tract. Moreover, the primary germ cell yolk sac tumor was found in the left ovary.


      In cases of concomitant gastric and ovarian tumors, metastatic disease (Krukenberg tumor) should be considered in the differential diagnosis. This concerns even adolescent patients. In particular cases, including tumors with germ cell components, primary debulking surgery is crucial for prognosis.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Pediatric and Adolescent Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Nogales FF
        • Bergeron C
        • Carvia RE
        • et al.
        Ovarian endometrioid tumors with yolk sac tumor component, an unusual form of ovarian neoplasm. Analysis of six cases.
        Am J Surg Pathol. 1996; 20: 1056
        • Horiuchi A
        • Osada R
        • Nakayama K
        • et al.
        Ovarian yolk sac tumor with endometrioid carcinoma arising from endometriosis in a postmenopausal woman, with special reference to expression of alpha-fetoprotein, sex steroid receptors, and p53.
        Gynecol Oncol. 1998; 70: 295
        • Abe A
        • Furumoto H
        • Yoshida K
        • et al.
        A case of ovarian endometrioid adenocarcinoma with a yolk sac tumor component.
        Int J Gynecol Cancer. 2008; 18: 168
        • Kane SV
        • Wuntkal R
        • Ramadwar M
        • et al.
        Ovarian endometrioid carcinoma with yolk sac component in a young patient: a diagnostic and therapeutic dilemma.
        Aust N Z J Obstet Gynaecol. 2004; 44: 364
        • Lopez JM
        • Malpica A
        • Deavers MT
        • et al.
        Ovarian yolk sac tumor associated with endometrioid carcinoma and mucinous cystadenoma of the ovary.
        Ann Diagn Pathol. 2003; 7: 300
        • McKenney JK
        • Heerema-McKenney A
        • Rouse RV
        Extra gonadal germ cell tumors: a review with emphasis on pathologic features, clinical prognostic variables, and differential diagnostic considerations.
        Adv Anat Pathol. 2007; 14: 69
        • Rutgers JL
        • Young RH
        • Scully RE
        Ovarian yolk sac tumor arising from an endometrioid carcinoma.
        Hum Pathol. 1987; 18: 1296
        • Kamoi S
        • Ohaki Y
        • Mori O
        • et al.
        A case of ovarian endometrioid adenocarcinoma with yolk sac tumor component in a postmenopausal woman.
        APMIS. 2002; 110: 508
        • Arai T
        • Kitayama Y
        • Koda K
        Ovarian mucinous cystadenocarcinoma with yolk sac tumor in a 71-year-old woman.
        Int J Gynecol Pathol. 1999; 18: 277
        • Zamecnik M
        • Voltr L
        • Stuk J
        • et al.
        Krukenberg tumor with yolk sac tumor differentiation.
        Int J Gynecol Pathol. 2008; 27: 223
        • Oberaigner W
        • Minicozzi P
        • Bielska-Lasota M
        • et al.
        Eurocare Working Group. Survival for ovarian cancer in Europe: the across-country variation did not shrink in the past decade.
        Acta Oncol. 2012; 51: 441
      1. Howlader N Noone AM Krapcho M SEER Cancer Statistics Review, 1975-2014. April 2017 (Available at:) (based on November 2016 SEER data submission, posted to the SEER web site)
        • Nagtegaal ID
        • Odze RD
        • Klimstra D
        • et al.
        WHO Classification of Tumors Editorial Board. The 2019 WHO classification of tumors of the digestive system.
        Histopathology. 2020; 76: 182
        • Hulikal N
        • Ray S
        • Thomas J
        • Fernandes DJ.
        Second primary malignant neoplasms: a clinicopathological analysis from a cancer centre in India.
        Asian Pac J Cancer Prev. 2012; 13: 6087
        • Cheng HY
        • Chu CH
        • Chang WH
        • et al.
        Clinical analysis of multiple primary malignancies in the digestive system: a hospital-based study.
        World J Gastroenterol. 2005; 11: 4215
        • Park JY
        • Kim DY
        • Suh DS
        • et al.
        Analysis of out- comes and prognostic factors after fertility-sparing surgery in malignant ovarian germ cell tumors.
        Gynecol Oncol. 2017; 145: 513
        • Matei L
        • Li W
        • Wang H
        • et al.
        Ovarian metastases resection from extragenital primary sites: outcome and prognostic factor analysis of 147 patients.
        BMC Cancer. 2012; 12: 278
        • Eisenkop SM
        • Nalick RH
        • Teng NN
        Modified posterior exenteration for ovarian cancer.
        Obstet Gynecol. 1991; 78: 879
        • Chi DS
        • Eisenhauer EL
        • Zivanovic O
        • et al.
        Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm.
        Gynecol Oncol. 2009; 114: 26
        • Chi DS
        • Musa F
        • Dao F
        • et al.
        An analysis of patients with bulky advanced stage ovarian, tubal, and peritoneal carcinoma treated with primary debulking surgery (PDS) during an identical time period as the randomized EORTC-NCIC trial of PDS vs neoadjuvant chemotherapy (NACT).
        Gynecol Oncol. 2012; 124: 10
        • Seamon LG
        • Richardson DL
        • Copeland LJ
        Evolution of the Gynecologic Oncology Group protocols in the treatment of epithelial ovarian cancer.
        Clin Obstet Gynecol. 2012; 55: 131
        • Mahdi H
        • Swensen RE
        • Hanna R
        • et al.
        Prognostic impact of lymphadenectomy in clinically early stage malignant germ cell tumor of the ovary.
        Br J Cancer. 2011; 105: 493
        • Kumar S
        • Shah JP
        • Bryant CS
        • et al.
        The prevalence and prognostic impact of lymph node metastasis in malignant germ cell tumors of the ovary.
        Gynecol Oncol. 2008; 110: 125
        • Dabbs DJ.
        Diagnostic Immunohistochemistry.
        Churchill Livingstone, Philadelphia, PA2002
        • Lai CR
        • Pan CC.
        Contribution immunocytochemistry in routine diagnostic cytology.
        Diagn Cytopathol. 1996; 14: 221
        • Shield PW
        • Perkins G
        • Wright RG
        Immunocytochemical staining of cytologic specimens. How helpful is it?.
        Am J Clin Pathol. 1996; 105: 157